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Purpose: To evaluate the effect of selective laser trabeculoplasty (SLT) in normal tension 
glaucoma (NTG) patients.
Patients and methods: A retrospective review was performed of NTG patients who had 
undergone SLT at the Duke University Eye Center between 12/2002 and 7/2005. For each 
eye of each patient at pre-laser and post-laser time points, the IOP measurements were sum-
marized by mean, standard deviation, and range. Then for each of these descriptive statistics, 
the differences between pre-laser and post-laser values were obtained. Statistical analysis was 
performed using a random effects model. Main outcome measures: difference in mean IOP, 
standard deviation of IOP, and range of IOP.
Results: Thirty-one eyes of 18 patients were included for analysis. The average of the mean 
  pre-operative IOP measurements was 14.3 ± 2.6 mmHg compared to 12.2 ± 1.7 mmHg 
(P , 0.001) post-operatively. The mean pre-operative standard deviation was 1.9 ± 0.9 mmHg 
compared to 1.0 ± 0.6 mmHg (P = 0.002) post-operatively while the mean IOP range prior to 
treatment was 4.5 ± 2.5 mmHg compared to 2.5 ± 1.9 mmHg (P = 0.017) after treatment.
Conclusion: In this pilot study, SLT was found to lower mean IOP and intervisit IOP   variation 
in NTG patients. Given the importance of IOP variation and its association with glaucoma 
  progression, measurement of IOP variation following treatment with SLT may be considered.
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Introduction
Normal tension glaucoma (NTG) was first described in 1857 by von Graefe.1 Its diag-
nosis is based on “characteristic optic nerve head cupping and glaucomatous visual field 
loss in the absence of a narrowed anterior chamber angle or an IOP above the statistical 
norm”.2 Specifically, the intraocular pressure (IOP) never exceeds 21 mmHg.3
Several studies, including the Early Manifest Glaucoma Trial, showed that   lowering 
intraocular pressure in primary open angle glaucoma decreases the incidence of 
  glaucoma progression.4 Data from the Collaborative Normal Tension Glaucoma Study 
demonstrated that patients with normal tension glaucoma also have delayed glaucoma 
progression with intraocular pressure reduction.5
IOP fluctuation and variation have also emerged as strong risk factors for glaucoma 
progression.6–9 In a recent study, Lee et al8 found that each unit increase in standard 
deviation of intervisit IOP resulted in at least a 4-fold increase in the risk of glau-
comatous visual field progression. In a NTG cohort, Collaer et al10 found a significant 
correlation between visual field deterioration and the range of IOP measured during 
day-long sequential IOP readings.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Thus, in both primary open angle glaucoma (POAG) 
in general and the subgroup of patients with NTG, there is 
evidence that both reduction of IOP as well as reduction of 
IOP fluctuation can decrease the incidence of visual field 
deterioration. A modality commonly used to treat POAG is 
laser trabeculoplasty. Multiple studies have demonstrated the 
efficacy of laser trabeculoplasty in lowering IOP in POAG 
patients.11–14 A few studies have also demonstrated that 
laser trabeculoplasty decreases IOP fluctuation in glaucoma 
patients.15–18
We sought to examine the role of selective laser trabe-
culoplasty (SLT) specifically in normal tension glaucoma 
patients. Therefore, we designed a study to retrospectively 
assess the effect of SLT on IOP as well as on IOP variation 
in NTG patients.
Methods
This study is a retrospective chart review of NTG patients who 
had undergone SLT at the Duke University Eye Center between 
December 2002 and July 2005. Institutional review board 
approval was obtained to access data in the patient charts.
A search through our billing codes during the above 
time period was performed for the codes for normal tension 
  glaucoma and SLT. All patients retrieved from this query 
were included in the study. Patients were excluded from 
study if they ever manifested an IOP greater than 21 in either 
eye. Other exclusion criteria were less than three pre-laser 
or three post-laser visits, prior laser trabeculoplasty or other 
prior glaucoma surgery.
The Coherent Selecta 7000 laser, a frequency-doubled 
q-switched neodymium:ytrium-aluminum-garnet laser, had 
been used to treat these patients. This laser has a wavelength 
532 nm with a pulse duration of 3 nanoseconds and a spot 
size of 400 µm. The Ritch trabeculoplasty lens was used 
with the mirrored thumbnail lens to focus the laser onto the 
trabecular meshwork. The energy level was initially set at 
0.7 millijoules (mJ) and the energy was varied such that at 
least 50% of the spots resulted in micro bubble formation. 
The total amount of delivered energy was recorded.
Postoperative management included one post laser eye-
drop each of 1% prednisolone acetate and of 0.15% brimoni-
dine. IOP was checked after 45 minutes to ensure the absence 
of an IOP spike. If the IOP was raised by more than 2 mmHg 
compared to pre laser IOP, one set of the above two drops 
were re-instilled and the IOP was rechecked in 30 minutes. 
Patients were then followed at 5 weeks and subsequently at 
3-month intervals. At each of these visits, IOP, medications 
as well as any complications were recorded.
Patients had multiple IOP measurements in each eye at 
pre-laser and post-laser time points. For the purposes of this 
study, only the IOP measurements one year prior and one year 
after laser were recorded. This one-year period was extended 
in either direction if there were not three measurements taken 
during this timeframe.
For each eye of each patient at pre-laser and post-laser 
time points, the measurements were summarized using the 
mean, standard deviation, minimum, maximum, and range 
of values of the multiple assessments of IOP. The range was 
defined as the difference between the maximum and   minimum 
IOP.
Then for each of these descriptive statistics, for each 
patient, the differences between pre-laser and post-laser 
  values were obtained. For example, the difference in mean 
IOP was computed as the mean of IOP measurements 
at the post-laser time points minus the mean of the IOP 
  measurements at the pre-laser time points. Likewise, the 
difference in the range of IOP measurements was computed 
as the range of IOP measurements from the post-laser time 
points minus the range of IOP measurements from the 
  pre-laser time points.
Once the differences between pre-laser and post-laser 
values for mean IOP, SD of IOP, minimum IOP, maximum 
IOP, and range of IOP were computed for each patient, a 
random effects model to test for statistical significance was 
applied. In this model, the patient was considered as a random 
effect to account for the dependence of measurements from 
two eyes of the same patient.
Further analysis examined the role of possible confound-
ing variables. These included the differences between pre-
laser and post-laser number of visits, number of medications 
and number of changes in medications. Specifically, the 
random effects model was used to test for changes in these 
variables. In addition, we conducted both univariate as well as 
multivariate analyses (also using the random effects model) 
to test whether inclusion of any of these possible confound-
ers altered our results with respect to changes in mean IOP, 
SD of IOP, and range of IOP. The SAS 9.1 software package 
(Cary, NC) was used for analysis.
Results
Thirty-one eyes of 18 normal tension glaucoma patients were 
included for analysis. The mean age was 61 years (range: 
44 to 82) and 72% were female. Four eyes of three patients 
underwent 180 degrees of treatment while the remaining 
27 eyes of 15 patients underwent 360 degrees of treatment 
with selective laser trabeculoplasty.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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The average of the mean pre-laser IOP measurements 
was 14.3 ± 2.6 mmHg while the average of the mean post-
laser IOP measurements was 12.2 ± 1.7 mmHg (P , 0.001) 
(Figure 1). The mean pre-laser IOP standard deviation was 
1.9 ± 0.9 mmHg while the mean standard deviation after laser 
was 1.0 ± 0.6 mmHg (P = 0.002) (Figure 2). The mean IOP 
range prior to laser treatment was 4.5 ± 2.5 mmHg. After laser 
treatment, the mean IOP range decreased to 2.5 ± 1.9 mmHg 
(P = 0.017) (Figure 3).
The mean maximum IOP decreased from 16.4 ± 3.0 mmHg 
prior to treatment to 13.6 ± 1.7 mmHg after treatment 
(P = 0.001). Before undergoing SLT, the mean minimum 
IOP recorded was 11.9 ± 3.0 mmHg. The mean minimum 
IOP recorded after SLT was 11.1 ± 2.0 mmHg (P = 0.073) 
(Table 1).
There was no significant difference between pre-laser and 
post-laser values for the number of clinic visits or for the num-
ber of medications being used. The mean number of pre-laser 
visits was 4.8 ± 1.5 while the mean number of post-laser visits 
was 4.9 ± 2.7 (P = 0.583). The mean number of medications 
at the time of laser was 1.68 ± 1.11 while the mean number of 
medications at last follow-up was 1.45 ± 1.18 (P = 0.178).
There was, however, a significant difference in the num-
ber of changes in medications before and after laser. The 
mean number of changes in medication prior to laser was 
0.9 ± 0.9 while the mean number of changes in medication 
after laser was 0.4 ± 0.9 (P = 0.039).
In both univariate and multivariate analyses, inclusion 
of these variables (number of visits, number of medications, 
and number of changes in medications) did not change the 
primary outcomes of change in mean IOP, change in SD of 
IOP, or change in range of IOP. All these changes remained 
statistically significant (Table 2). The mean duration of pre-
laser measurements was 7.8 months while the mean duration 
of post-laser follow-up measurements was 9.9 months. No 
patient had an adverse event.
Discussion
In normal tension glaucoma patients, our study showed that 
selective laser trabeculoplasty reduces mean intraocular 
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Figure 1 Boxplot of mean iOP pre-sLT vs post-sLT in nTg patients.
5.00
4.00
3.00
2.00
1.00
0.00
Pre
*
*
*
Time point
S
t
a
n
d
a
r
d
 
d
e
v
i
a
t
i
o
n
Post
Figure 2 Boxplot of standard deviation pre-sLT vs post-sLT in nTg patients.
13.00
14.00
12.00
11.00
10.00
9.00
8.00
7.00
*
*
*
6.00
5.00
4.00
3.00
2.00
1.00
0.00
Pre
Time point
R
a
n
g
e
Post
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pressure as well as intraocular pressure intervisit variation as 
defined both by standard deviation of IOP and IOP range.
In the context of this study, IOP variability can be affected 
by many variables. Among these are frequent changes in 
therapy as well as the number of adjunct topical hypotensive 
drops. Increased number of topical drops could possibly 
result in decreased fluctuation. Neither inclusion of number 
of medications nor inclusion of number of changes in medi-
cations altered our primary outcome variables. That is, even 
when number of changes in medications as well as number 
of medications are included in our multivariate analysis, SLT 
still decreased IOP variation.
Another possible confounder when measuring variability 
by standard deviation is that increased number of observa-
tions may lower standard deviation.8 Once again, in our 
sample, we found that number of visits had no impact on 
any of our results.
One previous study has examined the role of argon laser 
trabeculoplasty (ALT) in normal tension glaucoma patients.19 
Schwartz et al found that ALT reduced mean IOP as well 
as peak IOP. There was no comment as to the effect on IOP 
range or IOP standard deviation. This prior study included 
patients with previous intraocular pressures above 21 mmHg 
as well as patients with secondary glaucomas such as pig-
ment dispersion syndrome. We were careful in selecting our 
exclusion criteria so as to only include patients that met the 
strictest criteria for normal tension glaucoma.
Although several studies have demonstrated the   importance 
of IOP fluctuation in glaucoma progression,6–9 measurement 
of IOP fluctuation is still not routinely performed in the 
clinical setting. One possible reason is a lack of consensus 
on how to measure IOP fluctuation. Should we measure IOP 
range,6,9,10,17,18 or IOP standard deviation?7,8
Surprisingly, Lee et al8 found that increased IOP range 
was actually protective against glaucoma progression. As 
they noted, this was likely because the chronological order 
of low and high readings were not taken into account. It is 
likely that many patients who were successfully treated had 
a high range of IOP as they went from a high IOP to a low 
IOP, thus confusing the data. If we abandon IOP range for 
standard deviation, we need also to be wary as standard devia-
tion can be affected by the number of observations; too few 
observations will yield a large standard deviation.
The authors feel that either method is valid provided it 
is based on an adequate number of observations and is reset 
after any treatment intervention. Measuring IOP fluctuation 
allows practitioners another parameter by which to identify 
patients at risk of glaucoma progression and by which to 
monitor the effectiveness of their therapy.
Our study is limited by its retrospective nature as well 
as the relatively small sample size. However, even with this 
small sample, the results reached statistical significance. 
Also, many of our patients were using topical medications 
and although multivariate analysis showed no effect from 
number of medications or number of medication changes, 
given the small sample size, topical medication use may have 
affected IOP variation. However, in this group of patients, the 
distribution of use of prostaglandins and aqueous suppres-
sants was the same before as well as after the laser.
Our study is also limited by a follow-up period of less 
than one year. We cannot say for how long SLT will decrease 
mean IOP and IOP variation in NTG patients. Additionally, 
the decrease in variability in IOP measurements as a group 
may not necessarily indicate individual results.
To our knowledge, this is the first report showing that 
selective laser trabeculoplasty decreased mean IOP as well 
Table 1 iOP measures before and after sLT in nTg patients
  Pre-laser  
(mmHg)
Post-laser  
(mmHg)
Difference  
(mmHg)
P-value
Mean of average iOP 14.3 ± 2.6  12.2 ± 1.7 -2.03 ,0.001
Mean of standard deviation of iOP 1.9 ± 0.9  1.0 ± 0.6  -0.90 0.002
Mean of range of iOP 4.5 ± 2.5  2.5 ± 1.9  -2.02 0.017
Mean of maximum iOP 16.4 ± 3.0  13.6 ± 1.7  -2.86 0.001
Mean of minimum iOP 11.9 ± 3.0  11.1 ± 2.0  -0.84 0.073
Table 2 Univariate analyses of possible confounding variables 
showing no impact on the statistical significance of difference in 
mean iOP, sD of iOP, and range of iOP
Variable included P-value
Difference in  
mean IOP
Difference in  
SD of IOP
Difference in   
range of IOP
none ,0.001 0.002 0.017
number of visits ,0.001 0.002 0.004
number of  
medications
,0.001 0.003 0.031
number of changes  
in medications
,0.001 0.007 0.045Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
893
selective laser trabeculoplasty
as inter visit IOP variation in this pilot group of normal 
tension glaucoma patients. Given the importance of IOP 
variation and its association with glaucoma progression, 
measurement of IOP variation following treatment with SLT 
may be considered.
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